Segment Information (Tables)

6 Months Ended

Jun. 30, 2026

Schedule Of Segment Loss Significant Segment Expenses

The following table represents information about segment loss and significant segment expenses (in thousands):


	Three Months Ended June 30,					Six Months Ended June 30,
	2026		2025			2026		2025
Direct research and development expenses by program:
AP01	$	13,600	$	12,520		$	26,755	$	23,459
AP02		4,969		1,372			9,688		2,101
AP03		832		522			1,060		873
Unallocated research and development expenses:
Personnel-related (excluding stock-based compensation)		3,878		2,907			7,941		5,774
Facility and information technology allocated expenses and other research and development costs		468		386			788		656
General and administrative expenses:
Personnel-related (excluding stock-based compensation)		2,542		1,707			4,822		3,166
Facility expenses and information technology		528		144			821		291
General corporate expenses and professional fees		1,573		1,080			3,168		2,482
Other segment items (1)		545		(447	)		761		(1,108	)
Net loss	$	28,935	$	20,191		$	55,804	$	37,694

(1)

For the three months ended June 30, 2026 and 2025, other segment items consist of $2.5 million and $1.1 million of interest income, respectively, $0.2 million and $0.4 million of accretion of marketable securities, respectively, $2.8 million and $1.1 million of stock-based compensation expense, respectively, $0.3 million and zero of interest expense, respectively, and $178 thousand and $50 thousand of depreciation expense and other expenses, respectively. For the six months ended June 30, 2026 and 2025, other segment items consist of $3.4 million and $1.8 million of interest income, respectively, $0.4 million and $1.0 million accretion of marketable securities, respectively, $4.0 million and $1.7 million

of stock-based compensation expense, respectively, $0.4 million and zero of interest expense, respectively, and $228 thousand and $94 thousand of depreciation expense and other expenses, respectively.